News Coverage 10.17.19 By: Ryan Cross Share on Twitter Share on Facebook Share on LinkedIn Parker Institute spin-off launches to make CRISPR-edited cell therapies Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial